Mateon Therapeutics, Inc. MATN
No live quote for MATN yet.
Analyst view
Consensus: buy
Buy
Price target (mean) 2.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
- 2 months ago 1
- 3 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.16 | -0.16 – -0.16 | -0.15 | -6.7% | 0 | 0.0% | 1 |
| Next quarter | -0.16 | -0.16 – -0.16 | -0.13 | -23.1% | 0 | 0.0% | 1 |
| Current year | -0.57 | -0.57 – -0.57 | -0.54 | -5.6% | 0 | 0.0% | 1 |
| Next year | -0.58 | -0.58 – -0.58 | -0.57 | -1.8% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 26, 2017 | Maxim Group | Initiated | — | Buy |